A bankruptcy court judge has approved the settlement of thousands of lawsuits against Purdue Pharma, maker of the powerful prescription painkiller OxyContin.

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic.

A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids.

A judge intends to rule this week on a plan for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids.

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller.

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one.

The Supreme Court has rejected a settlement for OxyContin maker Purdue Pharma and members of the Sackler family who own the company.

The Sackler family members who own OxyContin maker Purdue Pharma say they're disappointed in the Supreme Court's rejection of a nationwide settlement that would've shielded them from civil lawsuits over the toll of opioids but also would've provided billions of dollars to combat the epidemic.

Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its marketing work with Purdue Pharma helped fuel an opioid addiction crisis.

The Supreme Court is wrestling with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The legality of an agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids is going before the Supreme Court.

The Kroger Co. has agreed to pay up to $1.4 billion to settle lawsuits over the toll of opioids.

The Supreme Court has temporarily blocked a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family who own the company to avoid civil lawsuits over the opioid crisis, a court has ruled.

A federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids.

More than a year after the maker of OxyContin reached a tentative settlement over the toll of opioids, the money isn't flowing yet.

Books that explore subjects from William Shakespeare and The Beatles to the lure of Mount Everest and life inside one of the world’s most secretive states are competing to be named the best-ever winner of Britain’s leading nonfiction book prize.

It’s not always emphasized given that she’s one of the most groundbreaking still photographers of the past 50 years.

CVS and Walgreens have agreed in principle to pay a total of about $10 billion to settle lawsuits over the toll of powerful prescription opioids.

Laura Poitras' Nan Goldin documentary "All the Beauty and the Bloodshed,” is having its world premiere at the Venice Film Festival on Saturday, where it is part of the main competition slate.

When bestselling author JD Vance founded “Our Ohio Renewal” a day after the 2016 presidential election, he promoted the charity as a vehicle for helping solve the scourge of opioid addiction he’d lamented in his memoir, “Hillbilly Elegy.”.

The Walgreens pharmacy chain has reached a $683 million settlement with the state of Florida in a lawsuit accusing the company of improperly dispensing millions of painkillers that contributed to the opioid crisis.

A woman who lost two sons to overdoses says she hopes a federal court clears the way for a settlement of lawsuits against OxyContin maker Purdue Pharma.

Lawmakers vowed to continue investigating consulting firm McKinsey after a hearing scrutinizing its work for the Food and Drug Administration even as it advised opioid makers on boosting sales.

A trial has opened in Florida’s opioid epidemic lawsuit against the Walgreens pharmacy chain.

The CVS drug store company and pharmaceutical companies will pay Florida a combined $860 million as part of the settlement of an opioid epidemic case.

The British Museum will remove the Sackler name from galleries, rooms and endowments following global outrage over the role the family played in the opioid crisis.

Yale University has begun removing the Sackler name from its campus several years after announcing it would no longer accept donations from the family that owns OxyContin maker Purdue Pharma.

A sense of closure is mixing with anger and pain for some of the nearly two dozen people who told their personal stories to members of the family that owns OxyContin maker Purdue Pharma.

Addiction and overdose survivors and those who have lost loved ones have unleashed their emotions on members of the family they blame for fueling the opioid epidemic.

A judge has indicated he is moving forward with a plan for the owners of OxyContin maker Purdue Pharma to pump at least another $1.2 billion into a nationwide settlement of lawsuits against over the toll of opioids.

OxyContin maker Purdue Pharma has reached a nationwide settlement over its role in the opioid crisis.

A judge said he is extending legal protections for members of the Sackler family who own OxyContin maker Purdue Pharma by another three weeks to buy time to work out a new settlement to thousands of lawsuits over the opioid crisis.

A report filed in federal bankruptcy court says members of the Sackler family who own Purdue Pharma are willing to increase their contribution to a nationwide opioid settlement by more than $1 billion.

OxyContin maker Purdue Pharma and a group of states have not been able to hammer out a new settlement so far as another mediation deadline has passed.

With a settlement possibly near, a judge is giving the family that owns OxyContin maker Purdue Pharma 16 more days of protection from lawsuits over the toll of opioids.

A judge has kept lawsuits against OxyContin maker Purdue Pharma and members of the Sackler family who own it on hold until Feb. 1 but ordered the parties to negotiate a new settlement.

A federal judge’s decision to reject a multibillion dollar opioid settlement involving OxyContin maker Purdue Pharma is being hailed as a step toward justice by advocates who have long called for greater accountability for the family that owns the company.

A federal judge has rejected OxyContin maker Purdue Pharma’s sweeping deal to settle thousands of lawsuits over the toll of opioids.

The Metropolitan Museum of Art is dropping the Sackler name from seven exhibition spaces amid growing outrage over the role the family may have played in the opioid crisis.

Lawyers for a handful of states say members of the Sackler family who own OxyContin maker Purdue Pharma are abusing the bankruptcy process.

A book about a wealthy American family whose actions helped unleash the United States’ opioid epidemic has won Britain’s leading nonfiction book prize.

Objections to a historic settlement with Purdue Pharma are mounting in the form of appeals.

A judge formally approved a plan Friday to turn OxyContin maker Purdue Pharma into a new company no longer owned by members of the Sackler family and with its profits going to fight the opioid epidemic.

The end of the Purdue Pharma bankruptcy case has left a bitter taste for those who wanted to see more accountability for members of the Sackler family.

A federal bankruptcy judge has approved with conditions a historic opioid settlement between Purdue Pharma and thousands of local and state governments.

A Purdue Pharma lawyer says states would get more money from settling with the company than if they were allowed to continue their lawsuits against the OxyContin maker and members of the Sackler family who own it.

A lawyer for Purdue Pharma says the company's settlement plan is the only way to avoid long and expensive litigation.

A member of the family that owns Purdue Pharma has once again stopped short of offering an apology or acknowledgment of responsibility in the opioid crisis.

Former Purdue Pharma president and chair Richard Sackler says he, his family and the company do not have any responsibility for the opioid crisis in the United States.

A member of the family that owns Purdue Pharma has told a court that the family will not contribute billions to abate the U.S. opioid crisis unless it is granted protection from current and future lawsuits.

Purdue Pharma's quest to settle thousands of lawsuits over OxyContin's toll has entered its final phase with the grudging acceptance of most of those who have claims against the company.

A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant — but it is far from tying a neat bow on the tangle of still-unresolved lawsuits surrounding the epidemic.

The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion deal to settle lawsuits brought by state and local governments across the country over the toll of prescription opioids, lawyers suing on behalf of local governments said.

OxyContin maker Purdue Pharma's plan to reorganize into an entity whose profits will be used to combat the U.S. opioid crisis got a big boost as 15 states have dropped their objections to the new business model.

A congressional committee has heard grievances against the owners of OxyContin maker Purdue Pharma as it considered legislation that would keep them from using a corporate bankruptcy as a shield for personal liability.

Massachusetts Attorney General Maura Healey says she opposes the current plan by Purdue Pharma to settle thousands of lawsuits over the opioid epidemic in part because it would help preserve wealth for members of the Sackler family who own the company.

A group of nearly half the state attorneys general said it was disappointed in the plan Purdue filed late Monday night in federal bankruptcy court and some said they would seek changes. Members of the Sackler family who own Purdue would contribute about $4.3 billion. AdCynthia Munger, of Wayne, Pennsylvania, said Purdue's plan is too focused on providing legal protections for members of the Sackler family. On a Facebook Live video Tuesday, Massachusetts Attorney General Maura Healey, a Democrat, said the payment from Sackler family members was too little. AdIn recent letters to a congressional committee, Sackler family members said those who previously served on Purdue's board of directors had combined net assets of $1.1 billion.

The global business consulting firm McKinsey & Company has agreed to a $573 million settlement over its role in the opioid crisis, according to a person with knowledge of the deal. (AP Photo/Toby Talbot, File)The global consulting firm McKinsey & Company agreed to pay nearly $600 million for its role in advising businesses on how to sell more prescription opioid painkillers amid a nationwide overdose crisis. Washington's attorney general announced a separate $13.5 million deal and West Virginia announced a $10 million settlement with the New York-based company. On a video call with journalists Thursday, North Carolina Attorney General Josh Stein said that McKinsey worked for Purdue for 15 years. AdIn a statement, New Jersey Attorney General Gurbir Grewal said that McKinsey would pay out more than it made advising companies on opioid sales.

The global business consulting firm McKinsey & Company has agreed to a $573 million settlement over its role in the opioid crisis, according to a person with knowledge of the deal. Without naming McKinsey, the attorneys general in at least North Carolina and West Virginia have scheduled announcements for Thursday morning regarding the opioid crisis. Purdue agreed to pay $225 million to the U.S. government. Members of the Sackler family who own the company agreed to pay the same amount in a separate settlement announced the same day. The company and family members reached separate agreements with U.S. Justice Department, both announced Oct. 21, 2020.

Members of the family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid crisis but have stopped short of apologizing or admitting wrongdoing. “I want to express my family’s deep sadness about the opioid crisis,” David Sackler, whose family owns Purdue Pharma, said at a rare appearance in a public forum. In contrast to the family members, Purdue CEO Craig Landau testified that the company accepts “full responsibility." The deal leaves open the possibility that family members could be criminally prosecuted. He also noted that about half of what family members took out of the company was paid in taxes.

Two members of the Sackler family who own OxyContin maker Purdue Pharma agreed to appear this week before a congressional committee investigating the family and the company's role in the national opioid addiction and overdose epidemic. The committee scheduled and then canceled a hearing earlier this month after family members would not commit to appearing. Under the deal, family members would also pay at least $3 billion in cash over time. Most Democratic state attorneys general oppose the settlement, saying they want more accountability for Sackler family members. The agreement did not result in criminal claims against Sackler family members, but left open the possibility that some could be brought.

The guilty pleas were entered by Purdue board chairperson Steve Miller on behalf of the company. They were part of a criminal and civil settlement announced last month between the Stamford, Connecticut-based company and the Justice Department. No criminal charges have been filed against family members, although their deal leaves open the possibility of that in the future. The attorneys general for about half the states opposed the federal settlement, as well as the company’s proposed settlement in bankruptcy court. In the bankruptcy case, Purdue has proposed transforming into a public benefit corporation with its proceeds going to help address the opioid crisis.

Proposed settlements between the federal government and OxyContin maker Purdue Pharma and its owners cleared a major legal hurdle Tuesday when a bankruptcy judge said they could move ahead. U.S. Bankruptcy Judge Robert Drain does not need to approve the Sacklers' federal settlement, but he did rule Tuesday that the payment portion of it was allowable. Drain, based in White Plains, New York, had a say on Purdue's federal settlement because the company is going through bankruptcy as part of its efforts to resolve the thousands of civil claims against it. Opponents argued that accepting the settlement now locks the judge into accepting the company’s proposal to resolve the lawsuits, including some terms that remain contentious. “Both entities, after all, have the public interest as their guiding imperative and share an interest in resolving the opioid crisis,” Drain said.

The Justice Department says on Wednesday, Purdue Pharma, the company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion. The deal does not release any of the company’s executives or owners — members of the wealthy Sackler family — from criminal liability, and a criminal investigation is ongoing. Family members said they acted “ethically and lawfully,” but some state attorneys general said the agreement fails to hold the Sacklers accountable. Purdue will make a direct payment to the government of $225 million, which is part of a larger $2 billion criminal forfeiture. Until recently, the Sackler name was on museum galleries and educational programs around the world because of gifts from family members.

In a series of non-binding votes, the FDA experts said that the updated OxyContin appeared to cut down abuse via snorting and injecting, compared to the original drug. But panelists overwhelmingly ruled that data from Purdue and other researchers did not show that the reformulation curbed abuse overall or led to fewer overdoses. Panelists said the shortcomings were due, in part, to the challenges of studying overdoses, which often involve multiple drugs. Purdue’s 2010 revamped OxyContin was the first of several opioids developed by drugmakers to help curb abuse. Purdue said in a statement following the meeting it would continue to work with the FDA as it reviewed the OxyContin studies.